» Articles » PMID: 33459853

Hyperattenuating Adrenal Lesions in Lung Cancer: Biphasic CT with Unenhanced and 1-min Enhanced Images Reliably Predicts Benign Lesions

Overview
Journal Eur Radiol
Specialty Radiology
Date 2021 Jan 18
PMID 33459853
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate usefulness of biphasic computed tomography (CT) in characterizing hyperattenuating adrenal lesions in lung cancer.

Methods: This retrospective study included 239 patients with lung cancer who underwent adrenal CT for hyperattenuating (> 10 Hounsfield unit) adrenal lesions. Adrenal CT comprised unenhanced and 1-min and 15-min enhanced images. We dichotomized adrenal lesions depending on benign or metastatic lesions. Reference standard for benignity was histologic confirmation or ≥ 6-month stability on follow-up CT. Two independent readers analyzed absolute (APW) or relative percentage wash-out (RPW) using triphasic CT, and enhancement ratio (ER) or percentage wash-in (PWI) using biphasic CT (i.e., unenhanced and 1-min enhanced CT). Criteria for benignity were as follows: criteria 1, (a) APW ≥ 60% or (b) RPW ≥ 40%, and criteria 2, (a) ER > 3 and (b) PWI > 200%. We analyzed area under the curve (AUC) and accuracy for benignity, and inter-reader agreement.

Results: Proportion of benign adrenal lesion was 71.1% (170/239). For criteria 1 and 2, AUCs were 0.872 (95% confidence interval [CI], 0.822-0.911) and 0.886 (95% CI, 0.838-0.923), respectively, for reader 1 (p = 0.566) and 0.816 (95% CI, 0.761-0.863) and 0.814 (95% CI, 0.759-0.862), respectively, for reader 2 (p = 0.955), and accuracies were 87.9% (210/239) and 86.2% (206/239), respectively, for reader 1 (p = 0.479) and 81.2% (194/239) and 80.3% (192/239), respectively, for reader 2 (p = 0.763). Weighted kappa was 0.725 (95% CI, 0.634-0.816) for criteria 1 and 0.736 (95% CI, 0.649-0.824) for criteria 2.

Conclusion: Biphasic CT can reliably characterize hyperattenuating adrenal lesions in patients with lung cancer.

Key Points: • Criteria from biphasic computed tomography (CT) for diagnosing benign adrenal lesions were enhancement ratio of > 3 and percentage wash-in of > 200%. • In the analysis by two independent readers, area under the curve between criteria 1 and 2 was not significantly different (0.872 and 0.886 for reader 1; 0.816 and 0.814, for reader 2; p > 0.05 for each comparison). • Wash-in characteristics from biphasic CT are helpful to predict benign adrenal lesions in lung cancer.

Citing Articles

Feasibility of extracellular volume fraction derived from single-phase spectral CT for differentiating between adrenal metastases and adenomas.

Sun M, Ma S, Tang G, Deng W, Peng Y, Yu S Abdom Radiol (NY). 2024; .

PMID: 39511028 DOI: 10.1007/s00261-024-04681-2.


Clinical‑imaging‑radiomic nomogram based on unenhanced CT effectively predicts adrenal metastases in patients with lung cancer with small hyperattenuating adrenal incidentalomas.

Cao L, Yang H, Yao D, Cai H, Wu H, Yu Y Oncol Lett. 2024; 28(2):340.

PMID: 38855505 PMC: 11157660. DOI: 10.3892/ol.2024.14472.


Acute exacerbation prediction of COPD based on Auto-metric graph neural network with inspiratory and expiratory chest CT images.

Wang S, Li W, Zeng N, Xu J, Yang Y, Deng X Heliyon. 2024; 10(7):e28724.

PMID: 38601695 PMC: 11004525. DOI: 10.1016/j.heliyon.2024.e28724.


Diagnostic performance of hepatic CT and chemical-shift MRI to discriminate lipid-poor adrenal adenomas from hepatocellular carcinoma metastases.

Nagayama Y, Hayashi H, Taguchi N, Yoshida R, Harai R, Kidoh M Abdom Radiol (NY). 2024; 49(5):1626-1637.

PMID: 38456897 DOI: 10.1007/s00261-024-04228-5.


Small hyperattenuating adrenal nodules in patients with lung cancer: Differentiation of metastases from adenomas on biphasic contrast-enhanced computed tomography.

Cao L, Zhang L, Xu W Front Oncol. 2023; 13:1091102.

PMID: 36865810 PMC: 9972082. DOI: 10.3389/fonc.2023.1091102.


References
1.
Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A . 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med. 2001; 42(12):1795-9. View

2.
Kumar R, Xiu Y, Yu J, Takalkar A, El-Haddad G, Potenta S . 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med. 2004; 45(12):2058-62. View

3.
Wilken Jensen C, Gram B . [Noonan's syndrome]. Ugeskr Laeger. 1987; 149(16):1067-8. View